AEZS - Aeterna Zentaris Inc.
| Previous Close | 1.8200 |
| Open | 1.8400 |
| Bid | 1.8800 x 1100 |
| Ask | 1.9100 x 3200 |
| Day's Range | 1.8400 - 1.9100 |
| 52 Week Range | 1.1200 - 3.2500 |
| Volume | 23,256 |
| Avg. Volume | 164,898 |
| Market Cap | 31.66M |
| Beta | 1.34 |
| PE Ratio (TTM) | 18.11 |
| EPS (TTM) | 0.1040 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- Simply Wall St.•4 days ago
What is Behind Aeterna Zentaris Inc’s (TSE:AEZS) Superior ROE?
This article is intended for those of you who are at the beginning of your investing journey and want to learn about Return on Equity using a real-life example. WithRead More...
- ACCESSWIRE•4 days ago
Aeterna Zentaris Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 10, 2018 / Aeterna Zentaris Inc. (NASDAQ: AEZS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 10, 2018 at 8:30 AM Eastern ...
- Associated Press•5 days ago
Aeterna Zentaris: 2Q Earnings Snapshot
The Summerville, South Carolina-based company said it had a loss of 16 cents per share. The drug developer posted revenue of $168,000 in the period. In the final minutes of trading on Thursday, the company's ...
- GlobeNewswire•5 days ago
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
CHARLESTON, S.C., Aug. 09, 2018-- Aeterna Zentaris Inc., a biopharmaceutical company engaged in developing and commercializing pharmaceutical products, today reported financial and operating results for ...
- GlobeNewswire•12 days ago
Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018
CHARLESTON, S.C., Aug. 02, 2018-- Aeterna Zentaris Inc. will announce its second quarter 2018 financial and operating results after market close on Thursday, August 9, 2018. The Company will host a conference ...
- GlobeNewswire•2 months ago
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
CHARLESTON, S.C., May 31, 2018-- Aeterna Zentaris Inc. announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna Zentaris GmbH in Frankfurt, Germany, ...
- Zacks•3 months ago
Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session
Mirati Therapeutics (MRTX) saw a big move last session, as its shares jumped nearly 14% on the day, amid huge volumes.
- Zacks•3 months ago
VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher
VIVUS (VVUS) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
- Zacks•3 months ago
MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session
MiMedx Group (MDXG) shares rose more than 11% in the last trading session, amid huge volumes.
- Zacks•3 months ago
Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher
Inovio Pharmaceuticals (INO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
- InvestorPlace•3 months ago
5 Top Profitable Stocks With Terrific Growth
A profitable company with strong fundamentals usually offers enormous gains to its investors. In this respect, we have used an accounting ratio to recognize a profitable company from a loss-making one. The best accounting tool to understand a company’s profitability position is ratio analysis.
- Zacks•3 months ago
Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors
Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors
- Zacks•3 months ago
5 Top Profitable Stocks With Terrific Growth in the Offing
A company with a high level of profitability is able to meet all its operating and non-operating costs and expenses, and still provides high returns to its investors.
- Benzinga•3 months ago
Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 7) Boston Scientific Corporation (NYSE: BSX ) DexCom, Inc. (NASDAQ: ...
- Associated Press•3 months ago
Aeterna Zentaris: 1Q Earnings Snapshot
The Montreal-based company said it had profit of 87 cents per share. The drug developer posted revenue of $24.7 million in the period. In the final minutes of trading on Monday, the company's shares hit ...
- ACCESSWIRE•4 months ago
Wired News – Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinson’s Disease Dementia
Stock Monitor: Aeterna Zentaris Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free research report on Anavex Life Sciences Corp. (NASDAQ: AVXL ...
- Associated Press•5 months ago
Aeterna Zentaris reports 4Q loss
On a per-share basis, the Montreal-based company said it had a loss of 3 cents. Losses, adjusted for pretax gains, came to 24 cents per share. The drug developer posted revenue of $178,000 in the period. ...
- ACCESSWIRE•5 months ago
Aeterna Zentaris Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 28, 2018 / Aeterna Zentaris Inc. (NASDAQ: AEZS ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 28, 2018, at 8:30 AM Eastern Time. ...
- Simply Wall St.•5 months ago
March Best Growth Stocks
Companies such as Emblem and Aeterna Zentaris have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolio should consider theseRead More...
